Indoleamine, 2-3 dioxygenase activity could be an early marker of graft rejection in heart transplantation

Transplantation Proceedings

Volumn 44, Issue 9, 2012, Pages 2645-2648

  Suarez Fuentetaja, N ^a   Domenech Garcia, N ^a   Paniagua Martin, M J ^a   Marzoa Rivas, R ^a   Barge Caballero, E ^a   Grille Cancela, Z ^a   Pombo Otero, J ^a   Muniz Garcia J ^b   Castro Beiras, A ^a   Crespo Leiro, M G ^a  

^a HOSPITAL JUAN CANALEJO   (Spain)

^b UNIVERSITY OF A CORUÑA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INDOLEAMINE 2,3 DIOXYGENASE;

ACUTE GRAFT REJECTION; ADULT; AGED; CONFERENCE PAPER; ENZYME ACTIVITY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART TRANSPLANTATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INCIDENCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMANS; INCIDENCE; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; ODDS RATIO; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; SPAIN; TIME FACTORS; TREATMENT OUTCOME; UP-REGULATION;

EID: 84869059047     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2012.09.036     Document Type: Conference Paper

References (17)

1. W.R. Mulley, D.J. Nikolic-Paterson Indoleamine 2,3-dioxygenase in transplantation Nephrology (Carlton) 13 2008 204
2. G.K. Lee, H.J. Park, M. Macleod Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division Immunology 107 2002 452
3. D.H. Munn, E. Shafizadeh, J.T. Attwood Inhibition of T cell proliferation by macrophage tryptophan catabolism J Exp Med 189 1999 1363
4. J. Quan, P.H. Tan, A. MacDonald Manipulation of indoleamine 2,3-dioxygenase (IDO) for clinical transplantation: promises and challenges Expert Opin Biol Ther 8 2008 1705
5. M.W. Taylor, G.S. Feng Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism FASEB J 5 1991 2516
6. U. Grohmann, C. Volpi, F. Fallarino Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy Nat Med 13 2007 579
7. D.H. Munn, M.D. Sharma, J.R. Lee Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase Science 297 2002 1867
8. J. Li, A. Meinhardt, M.E. Roehrich Indoleamine 2,3-dioxygenase gene transfer prolongs cardiac allograft survival Am J Physiol Heart Circ Physiol 293 2007 H3415
9. U. Grohmann, C. Orabona, F. Fallarino CTLA-4-Ig regulates tryptophan catabolism in vivo Nat Immunol 3 2002 1097
10. L.K. Jasperson, C. Bucher, A. Panoskaltsis-Mortari Indoleamine 2,3-dioxygenase is a critical regulator of acute graft-versus-host disease lethality Blood 111 2008 3257
11. D.H. Munn, A.L. Mellor Indoleamine 2,3-dioxygenase and tumor-induced tolerance J Clin Invest 117 2007 1147
12. E. Kwidzinski, J. Bunse, O. Aktas Indolamine 2,3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation FASEB J 19 2005 1347
13. D.H. Munn, M. Zhou, J.T. Attwood Prevention of allogeneic fetal rejection by tryptophan catabolism Science 281 1998 1191
14. T. Samikkannu, K.V. Rao, N. Gandhi Human immunodeficiency virus type 1 clade B and C Tat differentially induce indoleamine 2,3-dioxygenase and serotonin in immature dendritic cells: Implications for neuroAIDS J Neurovirol 16 2010 255
15. G. Brandacher, F. Cakar, C. Winkler Non-invasive monitoring of kidney allograft rejection through IDO metabolism evaluation Kidney Int 71 2007 60
16. T. Hautz, G. Brandacher, B. Zelger Indoleamine 2,3-dioxygenase and foxp3 expression in skin rejection of human hand allografts Transplant Proc 41 2009 509
17. G. Yu, M. Fang, M. Gong Steady state dendritic cells with forced IDO expression induce skin allograft tolerance by upregulation of regulatory T cells Transpl Immunol 18 2008 208